NEW YORK, Jan. 24, 2024 /PRNewswire/ -- SiriusXM (NASDAQ: SIRI) today announced that its Board of Directors declared a quarterly cash dividend of $0.0266 per share of common stock. This regular quarterly dividend is payable in cash on February 23, 2024 to stockholders of record at the close of business on February 9, 2024.
About Sirius XM Holdings Inc. SiriusXM is the leading audio entertainment company in North America with a portfolio of audio businesses including its flagship subscription entertainment service SiriusXM; the ad-supported and premium music streaming services of Pandora; an expansive podcast network; and a suite of business and advertising solutions. Reaching a combined monthly audience of approximately 150 million listeners, SiriusXM offers a broad range of content for listeners everywhere they tune in with a diverse mix of live, on-demand, and curated programming across music, talk, news, and sports. For more about SiriusXM, please go to: www.siriusxm.com.
Leading research and experience management firm Sogolytics will showcase innovations in HR and employee experience at UNLEASH America next week.
"With such a rapid evolution in the world of HR tech, we're seeing some major changes in how employers...
QNB Group, the largest financial institution in the Middle East and Africa, is proud to announce the signing of renowned actor Ahmed Helmy as its new brand ambassador.
The announcement comes in line with the Group's vision and the values of...
(BRK.A; BRK.B) ? Berkshire's operating results for the first quarters of 2024 and 2023 are summarized in the following paragraphs. However, we urge investors and reporters to read our 10-Q, which has been posted at www.berkshirehathaway.com. The...
Settlements have been reached with Deutsche Bank, TD, Nomura, Credit Suisse, RBC, Barclays, BNP, Citigroup, and Credit Agricole (the "Settling Defendants") in a proposed class action relating to supranational, sovereign, sub-sovereign, governmental,...
RaySearch Laboratories AB (publ) and C-RAD are pleased to announce a collaboration agreement, aiming at jointly developing innovative solutions and products to enhance the quality of radiation therapy.
The focus of the collaboration is to...
